ReviewFrontiers in physiology2025
Continuous personalized cerebrovascular reactivity-based physiologic metrics in neurocritical care: a narrative review of the current landscape, limitations, and future directions.
Review in Frontiers in physiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Interpolation and Imputation Strategies for Missing Segments in Continuous Pressure-Flow Cerebral Bio-Signals: A Systematic Scoping Review.Sensors (Basel, Switzerland) · 2026Article
- A noninvasive method for assessing optimal cerebral perfusion pressure.Critical care (London, England) · 2026Observational
- Editorial: Integrative approaches to acute brain injury: vascular, electrical, and metabolic interactions.Frontiers in physiology · 2026Article
- Intercerebral autoregulation index consistency in the derivation of CPPopt, MAPopt, and BISopt in humans: A scoping review.Physiological reports · 2025Article
- Optimal mean arterial pressure and its objective statistical associations with clinical outcomes and multimodal monitoring cerebral physiology: A systematic scoping review.Physiological reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Over the past several decades, significant progress has been made in our ability to achieve guideline-based cerebral physiologic targets for the management of moderate-to-severe traumatic brain injury (TBI). However, despite these advancements, there has been limited improvement in the long-term outcomes associated with this condition. It has been suggested that this is in part due to the generalized approach of current Brain Trauma Foundation guidelines. It has been demonstrated that significant heterogeneity in cerebral physiologic response to TBI exists between patients, and that it involves highly dynamic physiologic mechanisms which vary across a patient's time in the ICU. Therefore, an individualized management approach, that accounts for individual phenotype, injury heterogeneity, and the dynamic nature of cerebral physiology, is urgently needed. Recently, multiple personalized physiologic metrics, based on cerebrovascular reactivity optimization, have been proposed as potential tools to help address this increasingly important issue. These include the cerebral perfusion pressure optimum (CPPopt), mean arterial pressure optimum (MAPopt), bispectral index optimum (BISopt), and individualized intracranial pressure (iICP) thresholds. These metrics aim to shift neurocritical care management from static, population-based targets to dynamic, personalized targets that are tailored to a patient's real-time cerebral physiologic needs. In this narrative review, we will cover the topic of continuously derived cerebrovascular reactivity-based personalized physiologic metrics in neurocritical care, including the current states of the various existing techniques, their limitations, and future directions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.